• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 1 of 16

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10Next >End >>
05.10.2018Axonics Modulation Technologies, Inc. Announces Pricing of Initial Public Offering of Common Stock

Press Release

15.10.2018Aravive Biologics and Versartis Complete Merger

Press Release

29.08.2018KaNDy Therapeutics successfully raises £25 million in a Series C financing

Press Release

24.05.2018Iterum Therapeutics Announces Pricing of Initial Public Offering

Press Release

22.12.2017Aura Biosciences Completes $30 Million Series C Financing

Press Release

26.10.2017Acutus Medical® Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias

 

Press Release

28.09.2017NeRRe Therapeutics appoints Andrew Kay as Chairman of the Board

 

Press Release

27.09.2017KaNDy Therapeutics launched to advance a breakthrough treatment in Women's Health

 

Press Release

10.05.2017Iterum Secures $65 Million in Series B Financing

Press Release

03.05.2017Axonics Announces $14.5 Million First Close of Series C Financing

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2019 Advent Life Sciences